Cartilage Repair Implant Launched Across Europe
The Smith+Nephew implant aims to treat joint defects and improve function for patients.
Updated on Oct. 6, 2026 in Arthritis
Live Poll
Do you trust new medical implants more when they are backed by multi-year clinical trial evidence?
Smith+Nephew has launched its CARTIHEAL AGILI-C cartilage repair implant in several European nations. The device, which was introduced in the United States in 2024, is intended to help patients with cartilage defects.
Why it matters
This technology provides a new treatment option for cartilage damage in patients with or without osteoarthritis. It aims to address persistent pain and functional limitations by supporting tissue repair.
A multicenter randomized controlled trial demonstrated clinical superiority for the implant, showing sustained functional gains and pain relief over 60 months. These results represent a long-term assessment of the device in the study population.
The players
Smith+Nephew
A global medical technology company that produces orthopaedic reconstruction, sports medicine, and advanced wound management devices.
The details
The CARTIHEAL AGILI-C implant uses a biphasic scaffold constructed from naturally occurring aragonite, a form of calcium carbonate. During a surgical procedure, physicians deliver this scaffold to the site of cartilage damage to promote natural bone and cartilage restoration. This mechanism allows the scaffold to integrate into the joint environment to facilitate healing of structural defects.
Timeline
The CARTIHEAL implant was introduced in the United States in 2024.
The ICRS Summit will take place in Porto, Portugal, from October 8-10, 2026.
Health Landscape
This launch follows the presentation of clinical trial findings at the International Cartilage Regeneration and Joint Preservation Society summit, where medical experts evaluate new orthopaedic technologies. It sits within a competitive landscape of regenerative therapies aiming to bridge the gap between initial injury and joint replacement.
If you are experiencing persistent joint pain or have been diagnosed with cartilage defects, it is worth discussing with your doctor whether new surgical repair technologies are appropriate for your specific condition. Because treatment paths vary by individual anatomy and disease stage, a surgeon can help you weigh these options against existing procedures.
The takeaway
The CARTIHEAL AGILI-C implant offers a new approach for repairing cartilage through a specialized aragonite scaffold. Discuss the latest surgical techniques with an orthopaedic specialist to understand if your joint symptoms require intervention beyond conservative management.
Further reading
Learn more about evolving options for joint health in our Arthritis section.
Live Poll
Do you trust new medical implants more when they are backed by multi-year clinical trial evidence?
